For the year ending 2025-12-31, IBO has $17,405K in assets. $1,850K in debts. $3K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3 | |||
| Accounts receivable | 5 | |||
| Inventory | 63 | |||
| Current portion of notes receivable | 198 | |||
| Prepaid expenses and other current assets | 142 | |||
| Total current assets | 411 | |||
| Other intangible assets, net | 16,994 | |||
| Total assets | 17,405 | |||
| Accounts payable | 347 | |||
| Accrued expenses | 194 | |||
| Due to related party | 621 | |||
| Total current liabilities | 1,162 | |||
| Deferred tax liability, net | 688 | |||
| Total liabilities | 1,850 | |||
| Common stock, 0.001 par value 4,000,000,000 shares authorized, 104,621,231 shares issued and outstanding (11,503,955 on december 31, 2024) | 105 | |||
| Additional paid-in capital | 62,011 | |||
| Accumulated deficit | -49,507 | |||
| Total stockholders equity of the company | 12,609 | |||
| Non-controlling interest in subsidiaries | 2,946 | |||
| Total stockholders equity | 15,555 | |||
| Total liabilities and stockholders equity | 17,405 | |||
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)